Member Info for Lazarus2

Just back from appointment and great to see the positivity on the board again. Nothing will happen overnight but this sp is a steal. Very impressed by the presentation and JR came across really well and as a man on top of his game. Difficult to pick holes in this and - as the thread suggests - we have our Sareum back indeed.

Yep! thats how I heard it. Regular updates to come. Formulation change could well be working. JR sounds confident

737 has potential for first in class - proven to be well tolerated in clinical studies.

Very good presentation from JR - opportunity for partnering

1802 has potential both as a single agent and in combo with existing therapies. 1801 priority so 1802 being packaged for early licensing possibly in blood cancers. CNS development into second phase.

Superior efficacy of 1801 over competitors presented by JR and supported with data. Absolutely key will be the Tox study.

Partnering for 737 is "moving forwards" and made more attractive by IP extension.

I wouldn't call that a family embarrassment Potnak. All to play for IMO.

I will only be able to listen to the first 35 minutes of the presentation as I have a 3pm appointment. I will catch up later though. Very much looking forwards to a positive and forward looking Q&A session.

There are buys going through on HL at 15p but not showing here. Must be saving them up. Probably holding the sp down until the meeting. 13.6 to sell

Colbaltblue you are having a real go here with constant negative thread titles and any negative angle you can find. Bizarre behaviour for somebody who is meant to be invested. I now do not believe a word you say as you clearly have an agenda. No question. So I have changed the thread title to a more positive one. And yes, I get asked regularly by Mrs Laz who has given up completely. Luckily, other investments have bailed me out big time as well as the extension and other items paid for in the Covid spike.

Anyone with any gumption would have sliced their original stake on the Covid spike. I certainly did and more. So all of the naysayers are back out in force. Do they really go to football matches to boo their own teams? Talking down your investments and saying you are in it to the end is quite bizarre IMO. For the benefit of the uninitiated, it is best to buy a share when the share is unloved not when it is the darling of the AIM. (Buy cheap, sell high).

Nobody here is ruling out the need for a placing nor are we ruling out the possibility of a deal. You pays your money, you takes your chance.

Hi Christadog.

Been a couple of trades. Unless they are trading off book then they are short of shares.

As is mine PCS - encouraging to see the new compound being developed too. Lots to look forwards to by the sounds of it and a deal of some sort would alleviate the need for a placing. Still all to play for in my view

This is a good update with seemingly, progress on all fronts. It isn’t overstated but quietly confident. Patent to 2041 is encouraging and will pave the way for serious discussion with would-be suitors. 1801 still the focus of attention and has moved forwards on all fronts.

I think you have not done your research Punter.

….for half yearly and an investor meet opportunity.

Agreed Bailiff - The Buyer may just have to pay that little bit more. No sellers around as of yet it would seem. Shares appear to be in sticky hands.

Incidentally, last years half yearly report came on the 25th March. Sunday sees the beginning of March, so a little over 3 weeks or so until we at least get an update. It would be great to have something come in from left field in relation to 1801 or 737. Or even a RNS notification of HNWI buying in!!

I agree Potnak and it is good to see a bit of positivity. Best time to buy a share with potential is when it is unloved - that is how to make money. Otherwise you are in danger of being spiked once loved.

Thanks Citizen. Breath of fresh air.